Miyoung Yoon

Reducing exposure to high levels of perfluorinated compounds in drinking water improves reproductive outcomes: evidence from an intervention in Minnesota

Nano-based smart pesticide formulations: Emerging opportunities for agriculture

Perfluorooctane Sulfonate Induces Autophagy-Dependent Apoptosis through Spinster 1-Mediated lysosomal-Mitochondrial Axis and Impaired Mitophagy

Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women

Developmental Exposures to Perfluoroalkyl Substances (PFASs): An Update of Associated Health Outcomes

Cell Biology of Ischemia/Reperfusion Injury

A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects

Environmental exposure to microplastics: An overview on possible human health effects

The use of zero-valent iron for groundwater remediation and wastewater treatment: A review

The impact of environmental metals in young urbanites’ brains

Mechanisms of lead and manganese neurotoxicity

Intrauterine exposure to perfluorinated compounds and overweight at age 4: A case-control study

The limitations of applying zero-valent iron technology in contaminants sequestration and the corresponding countermeasures: The development in zero-valent iron technology in the last two decades (1994–2014)

Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion

Cytotoxic effects of commonly used nanomaterials and microplastics on cerebral and epithelial human cells

Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts

Artificial intelligence in drug discovery and development

Predictors of Per- and Polyfluoroalkyl Substance (PFAS) Plasma Concentrations in 6–10 Year Old American Children

Physicologically Based Toxicokinetic Models of Tebuconazole and Application in Human Risk Assessment

Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants

PFAS Environmental Pollution and Antioxidant Responses: An Overview of the Impact on Human Field

Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

Serum Perfluorooctanoic Acid and Birthweight

Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight Gain

A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes

Magnetite pollution nanoparticles in the human brain

Per- and Polyfluoroalkyl Substances Differentially Inhibit Placental Trophoblast Migration and Invasion In Vitro

Plasma Concentrations of Per- and Polyfluoroalkyl Substances at Baseline and Associations with Glycemic Indicators and Diabetes Incidence among High-Risk Adults in the Diabetes Prevention Program Trial

Per- and polyfluoroalkyl substances in the environment

PubChem in 2021: new data content and improved web interfaces

Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

Arsenic Removal with Composite Iron Matrix Filters in Bangladesh: A Field and Laboratory Study

Advancing Computational Toxicology in the Big Data Era by Artificial Intelligence: Data-Driven and Mechanism-Driven Modeling for Chemical Toxicity

A Permeability-Limited Physiologically Based Pharmacokinetic (PBPK) Model for Perfluorooctanoic acid (PFOA) in Male Rats

Analysis of biomarker utility using a PBPK/PD model for carbaryl

Analysis of Manganese Tracer Kinetics and Target Tissue Dosimetry in Monkeys and Humans with Multi-Route Physiologically Based Pharmacokinetic Models

Quantitativein vitrotoin vivoextrapolation of cell-based toxicity assay results

Physiologically Based Pharmacokinetic Modeling of Fetal and Neonatal Manganese Exposure in Humans: Describing Manganese Homeostasis during Development

Can the observed association between serum perfluoroalkyl substances and delayed menarche be explained on the basis of puberty-related changes in physiology and pharmacokinetics?

Developmental Expression of Aldehyde Dehydrogenase in Rat: a Comparison of Liver and Lung Development

Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK)

Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT—Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment